Few points on anti-D immunoglobulin administration in Rh-negative pregnant women / 中华围产医学杂志
Chinese Journal of Perinatal Medicine
;
(12): 152-154, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-885532
ABSTRACT
Anti-D immunoglobulin effectively prevents RhD alloimmunity and has a low incidence of adverse reactions, which are generally mild. A consensus is yet to be reached regarding the clinical norms in China. We provide an overview of anti-D immunoglobulin in preventing RhD alloimmunity, including its mechanism of action, dose-effect, and safety, the timing and rationality of prenatal antibody screening, the timing and dosage of routine prenatal administration of anti-D immunoglobulin, as well as the prenatal indications for an additional dosage of anti-D immunoglobulin and postpartum prevention based on evidence from both domestic and abroad.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Perinatal Medicine
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS